Current research status and prospects in artificial intelligence-assisted clinical decision support systems for lung cancer
- VernacularTitle:人工智能辅助肺癌临床决策支持系统的研究现状与展望
- Author:
Ruixin ZHANG
1
;
Jun ZHOU
2
;
Hanwen ZHU
3
;
Xinchen SHEN
1
;
Kaiyuan LI
1
,
4
;
Tao CHEN
1
;
Jialiang WEN
1
;
Jiajun DENG
1
;
Yunlang SHE
1
;
Deping ZHAO
1
;
Dong XIE
1
;
Chang CHEN
1
Author Information
- Publication Type:Journal Article
- Keywords: Artificial intelligence; lung neoplasms; decision support systems, clinical; deep learning; precision medicine; multiomics
- From: Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(11):1742-1750
- CountryChina
- Language:Chinese
- Abstract: Lung cancer ranks first in both incidence and mortality among all malignancies worldwide. Although low-dose computed tomography (LDCT)-based screening has reduced lung cancer mortality to a certain extent, the prognosis of lung cancer patients still leaves much room for improvement. In recent years, artificial intelligence (AI) technologies represented by deep learning have developed rapidly, span the entire diagnostic and therapeutic chain of lung cancer, including screening and early diagnosis, precise staging and treatment decision-making, perioperative management, pathological and molecular diagnosis, and prognostic evaluation, and have gradually evolved from single-modality, single-task architectures toward multimodal fusion models and even general-purpose medical foundation models. This article summarizes the research progress of AI-assisted clinical decision support systems for lung cancer and discusses the challenges and future directions of their clinical translation.
